Win-62005 is primarily utilized in research settings, particularly in the study of neurological and psychiatric disorders. It acts as a selective antagonist for certain serotonin receptors, making it valuable for understanding the role of these receptors in brain function and behavior. Researchers use it to investigate conditions such as anxiety, depression, and schizophrenia, as it helps to elucidate the mechanisms underlying these disorders. Additionally, it has been employed in pharmacological studies to explore potential therapeutic targets for developing new treatments. Its application is largely confined to preclinical and experimental studies, contributing to advancements in neuroscience and drug development.